Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Codexis stock

Own Codexis stock in just a few minutes.

Posted

Fact checked

Codexis, Inc is a biotechnology business based in the US. Codexis shares (CDXS) are listed on the NASDAQ and all prices are listed in US Dollars. Codexis employs 161 staff and has a trailing 12-month revenue of around USD$66.7 million.

How to buy shares in Codexis

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Codexis. Find the stock by name or ticker symbol: CDXS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Codexis reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Codexis, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Codexis. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Codexis share price

Use our graph to track the performance of CDXS stocks over time.

Codexis shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$8.43 - USD$29.56
50-day moving average USD$25.197
200-day moving average USD$17.5993
Wall St. target priceUSD$24.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.26

Buy Codexis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Codexis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Codexis financials

Revenue TTM USD$66.7 million
Gross profit TTM USD$19 million
Return on assets TTM -9.21%
Return on equity TTM -21.44%
Profit margin -31.08%
Book value $1.533
Market capitalisation USD$1.4 billion

TTM: trailing 12 months

Shorting Codexis shares

There are currently 5.0 million Codexis shares held short by investors – that's known as Codexis's "short interest". This figure is 9.4% down from 5.5 million last month.

There are a few different ways that this level of interest in shorting Codexis shares can be evaluated.

Codexis's "short interest ratio" (SIR)

Codexis's "short interest ratio" (SIR) is the quantity of Codexis shares currently shorted divided by the average quantity of Codexis shares traded daily (recently around 678411.08108108). Codexis's SIR currently stands at 7.4. In other words for every 100,000 Codexis shares traded daily on the market, roughly 7400 shares are currently held short.

However Codexis's short interest can also be evaluated against the total number of Codexis shares, or, against the total number of tradable Codexis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Codexis's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Codexis shares in existence, roughly 80 shares are currently held short) or 0.0812% of the tradable shares (for every 100,000 tradable Codexis shares, roughly 81 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Codexis.

Find out more about how you can short Codexis stock.

Codexis share dividends

We're not expecting Codexis to pay a dividend over the next 12 months.

Codexis share price volatility

Over the last 12 months, Codexis's shares have ranged in value from as little as $8.43 up to $29.56. A popular way to gauge a stock's volatility is its "beta".

CDXS.US volatility(beta: 1.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Codexis's is 1.1483. This would suggest that Codexis's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Codexis overview

Codexis, Inc. discovers, develops, and sells protein catalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site